Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.

Proceedings of the National Academy of Sciences of the United States of America - 17 Feb 1998

Su Z, Goldstein N I, Fisher P B

Abstract excerpt

The genetic alterations and molecular events mediating human prostate cancer development and progression remain to be defined. Rapid expression cloning and differential RNA display detect a putative oncogene, prostate tumor-inducing gene 1 (PTI-1), that is differentially expressed in human prostate (as well as breast, colon, and small cell lung) cancer cell lines, patient-derived prostate carcinomas, and blood...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Division
Share to Cell Transformation, Neoplastic
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, Dominant

Share to Oncogenes

Share to Phenotype

Share to Protein Biosynthesis

Source

Open in PubMed Open full text

Identifiers

PMID: 9465091
DOI: 10.1073/pnas.95.4.1764
PMCID: PMC19182

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.PMID 9465091Read ↗

Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display.Semantic proximity Read ↗

Tazarotene-Induced Gene 1 (TIG1) Expression in Prostate Carcinomas and Its Relationship to TumorigenicitySemantic proximity Read ↗

Stable Suppression of Tumorigenicity by Pin1-Targeted RNA Interference in Prostate CancerSemantic proximity Read ↗

A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancerSemantic proximity Read ↗

UXT interacts with the transcriptional repressor protein EVI1 and suppresses cell transformation.Semantic proximity Read ↗

Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo.Semantic proximity Read ↗

Endothelin-converting enzyme-1 (ECE-1) is post-transcriptionally regulated by alternative polyadenylation.Semantic proximity Read ↗

High Expression of a New Marker PCA-1 in Human Prostate CarcinomaSemantic proximity Read ↗

RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cellsSemantic proximity Read ↗

A novel approach to identify driver genes involved in androgen-independent prostate cancerSemantic proximity Read ↗

MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer.Semantic proximity Read ↗

Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.